Edition: India  
 
> >

FDA panel votes in favor of Spark's blindness gene therapy

Reuters India Thursday, 12 October 2017 ()
(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed

News video: FDA Panel Considering Gene Therapy For Children With Eye Disease

FDA Panel Considering Gene Therapy For Children With Eye Disease 00:37

A Food and Drug Administration advisory panel was ready Thursday to recommend approval for a gene therapy that could bring sight to children with a rare type of inherited vision loss. The treatment Replaces a nonworking gene with a new one is restoring sight to those with the inherited retinal...

You Might Like


Recent related news

Spark's blindness gene therapy reviewed by U.S. FDA

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit...
Reuters India - Health

U.S. FDA finds Spark's blindness treatment initially effective

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit...
Reuters India - Health

The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual 2017 European Advanced Therapies Investor Day

LONDON, UNITED KINGDOM and WASHINGTON, DC--(Marketwired - Oct 17, 2017) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization...
Marketwired - Press Releases

AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen

AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen
CHAPEL HILL, N.C.--(BUSINESS WIRE)--AskBio Pharmaceuticals and Columbus Venture Partners Launch Gene Therapy Company Viralgen
Business Wire - Press ReleasesAlso reported by •Reuters India

New gene therapy treatment could hit $1M per patient because of additional costs

The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Delawareonline - USAlso reported by •Reuters India

Spark gene therapy improves vision, at least in short term: FDA

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness improves vision, though it is unclear whether the benefit...
Reuters India - Health


Other recent news in Health

GP services in NORTHERN IRELAND are 'in crisis'Inpatient mental HEALTH CARE for new mothers 'unacceptable'
Trump's DRUG CZAR nominee withdraws from considerationTOM MARINO withdraws as Trump nominee for drug czar after lobbying reports

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter